Last reviewed · How we verify
Vasomotor rhinitis
Approved treatments
- Chlophedianol
- Doxylamin · St. Petersburg Bekhterev Research Psychoneurological Institute
- Drixoral · Merck & Co.
- Hispril · GSK
- Pyribenzamin · Novartis
- Pyrilamine · Impax Labs
- Semprex-D · Auxilium Pharms Inc
- Propadrine · Alpharma Us Pharms
- Phenazoline · Novartis
- Tussionex Pennkinetic · Bayer
- Unisom · Chattem
- Marezine · GSK
- Seldane
- Carbaphen
- Sudafed PE · Generic (multiple manufacturers)
- Perazyl
- Benadryl · Brooke Army Medical Center
- Phenergan Vc W/ Codeine · ANI Pharmaceuticals
- Beconase Aq
- Benadryl · Johnson & Johnson (McNeil Consumer Healthcare)
- Rhinocort · Marinomed Biotech AG
- Zyrtec · Generic (originally UCB Pharma)
- Akovaz
Akovaz works by releasing norepinephrine, a natural chemical in the body that helps to relieve symptoms of respiratory and allergic conditions. - Pentoxiverine
- Rhinol
Rhinol works by activating the alpha-2A adrenergic receptor to constrict blood vessels in the nasal passages. - Clarinex · Generic (originally Schering-Plough/MSD)
Active metabolite of loratadine with higher potency at H1 receptors and additional anti-inflammatory properties. - Claritin · Generic (originally Schering-Plough)
- Thenylene
- Phenergan · Generic (originally Wyeth/Pfizer)
- Sudafed · Generic (multiple manufacturers)
- Astelin · Bayer
- Dexchlorpheniramine Maleate
- Tussionex Pennkinetic · Bayer
- Actidil · Novartis
- Dimetane-Dx
- Methylscopolamine · Fougera Pharms
- Karbinal Er · Mcneil
Karbinal Er works by blocking the histamine H1 receptor, a key player in the body's allergic response. - Azatidine
- Tavist
- Delsym · Generic (originally Roche)
- Beclometasone · Imperial College London
- Clemastin · Technical University of Munich
- phenylpropanol
- Desloratadin · Max Zeller Soehne AG
- scopolamin · University Hospital, Angers
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vasomotor rhinitis patent landscape — cliff calendar, originator estates, attackable patents
- Vasomotor rhinitis treatment landscape brief
- Vasomotor rhinitis treatment updates RSS
Frequently asked questions about Vasomotor rhinitis
What drugs treat Vasomotor rhinitis?
Tracked treatments include Chlophedianol, Doxylamin, Drixoral, Hispril, Pyribenzamin, Pyrilamine, Semprex-D, Propadrine.
What is the treatment for Vasomotor rhinitis?
Standard treatment for Vasomotor rhinitis includes Chlophedianol, Doxylamin, Drixoral, Hispril, Pyribenzamin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vasomotor rhinitis patent cliff · Vasomotor rhinitis CI report
- Treatment: Chlophedianol
- Treatment: Doxylamin · St. Petersburg Bekhterev Research Psychoneurological Institute
- Treatment: Drixoral · Merck & Co.
- Treatment: Hispril · GSK
- Treatment: Pyribenzamin · Novartis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing